188 related articles for article (PubMed ID: 24040850)
21. Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada.
Rahme E; Barkun A; Nedjar H; Gaugris S; Watson D
Am J Gastroenterol; 2008 Apr; 103(4):872-82. PubMed ID: 18371130
[TBL] [Abstract][Full Text] [Related]
22. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
MacLaren R; Reynolds PM; Allen RR
JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
[TBL] [Abstract][Full Text] [Related]
23. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
24. Risk factor profiles, drug usage, and prevalence of aspirin-associated gastroduodenal injuries among high-risk cardiovascular Japanese patients: the results from the MAGIC study.
Uemura N; Sugano K; Hiraishi H; Shimada K; Goto S; Uchiyama S; Okada Y; Origasa H; Ikeda Y;
J Gastroenterol; 2014 May; 49(5):814-24. PubMed ID: 23754512
[TBL] [Abstract][Full Text] [Related]
25. Concurrent Use of Low-Dose Aspirin and Omega-3 Fatty Acids and Risk of Upper Gastrointestinal Complications: A Cohort Study with Nested Case-Control Analysis.
Roberto G; Simonetti M; Cricelli C; Cricelli I; Giustini SE; Parretti D; Lapi F
Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):136-42. PubMed ID: 26280541
[TBL] [Abstract][Full Text] [Related]
26. Underutilization of gastroprotective strategies in aspirin users at increased risk of upper gastrointestinal complications.
Targownik LE; Metge CJ; Leung S
Aliment Pharmacol Ther; 2008 Jul; 28(1):88-96. PubMed ID: 18410563
[TBL] [Abstract][Full Text] [Related]
27. Clinical impact of drug-drug interaction between aspirin and prednisolone at a cancer center.
Koomanan N; Ko Y; Yong WP; Ng R; Wong YP; Lim SW; Salim A; Chan A
Clin Ther; 2012 Dec; 34(12):2259-67. PubMed ID: 23200184
[TBL] [Abstract][Full Text] [Related]
28. Increased risk of exacerbating gastrointestinal disease among elderly patients following treatment with calcium channel blockers.
Hamada A; Ishii J; Doi K; Hamada N; Miyazaki C; Hamada T; Ohwaki Y; Wada M; Nakashima K
J Clin Pharm Ther; 2008 Dec; 33(6):619-24. PubMed ID: 19138239
[TBL] [Abstract][Full Text] [Related]
29. Time-trends in the prescribing of gastroprotective agents to primary care patients initiating low-dose aspirin or non-steroidal anti-inflammatory drugs: a population-based cohort study.
Warlé-van Herwaarden MF; Koffeman AR; Valkhoff VE; 't Jong GW; Kramers C; Sturkenboom MC; De Smet PA
Br J Clin Pharmacol; 2015 Sep; 80(3):589-98. PubMed ID: 25777983
[TBL] [Abstract][Full Text] [Related]
30. Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
Gurbel PA; Bliden KP; Fort JG; Jeong YH; Shuldiner A; Chai S; Gesheff T; Antonino M; Gesheff M; Zhang Y; Tantry US
Am Heart J; 2013 Feb; 165(2):176-82. PubMed ID: 23351820
[TBL] [Abstract][Full Text] [Related]
31. Prevention of Upper Gastrointestinal Ulcer and Complications in Low-Dose Aspirin Users.
Sugano K
Curr Pharm Des; 2015; 21(35):5082-8. PubMed ID: 26369684
[TBL] [Abstract][Full Text] [Related]
32. Use of proton pump inhibitors and the risk of coronary events in new users of low-dose acetylsalicylic acid in UK primary care.
García Rodríguez LA; Johansson S; Nagy P; Cea Soriano L
Thromb Haemost; 2014 Jan; 111(1):131-9. PubMed ID: 24153412
[TBL] [Abstract][Full Text] [Related]
33. Comparative risk of Clostridium difficile infection between proton pump inhibitors and histamine-2 receptor antagonists: A 15-year hospital cohort study using a common data model.
Seo SI; You SC; Park CH; Kim TJ; Ko YS; Kim Y; Yoo JJ; Kim J; Shin WG
J Gastroenterol Hepatol; 2020 Aug; 35(8):1325-1330. PubMed ID: 31970824
[TBL] [Abstract][Full Text] [Related]
34. [Risk and prevention of gastrointestinal complications due to low-dose aspirin and other antiplatelet agents].
Bretagne JF
Rev Prat; 2008 Sep; 58(13):1434-6, 1439-40. PubMed ID: 18924327
[TBL] [Abstract][Full Text] [Related]
35. Gastroprotective strategies in chronic NSAID users: a cost-effectiveness analysis comparing single-tablet formulations with individual components.
de Groot NL; Spiegel BM; van Haalen HG; de Wit NJ; Siersema PD; van Oijen MG
Value Health; 2013; 16(5):769-77. PubMed ID: 23947970
[TBL] [Abstract][Full Text] [Related]
36. Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product.
Kelly JP; Kaufman DW; Jurgelon JM; Sheehan J; Koff RS; Shapiro S
Lancet; 1996 Nov; 348(9039):1413-6. PubMed ID: 8937281
[TBL] [Abstract][Full Text] [Related]
37. Review of pharmacokinetic and pharmacodynamic modeling and safety of proton pump inhibitors and aspirin.
Gesheff MG; Franzese CJ; Bliden KP; Contino CJ; Rafeedheen R; Tantry US; Gurbel PA
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):645-53. PubMed ID: 25098174
[TBL] [Abstract][Full Text] [Related]
38. Common drugs can harm elderly patients.
Voelker R
JAMA; 2009 Aug; 302(6):614-5. PubMed ID: 19671895
[No Abstract] [Full Text] [Related]
39. Gastroprotection in NSAID and low-dose aspirin users: a cross-sectional study in primary care.
Lanas A; Plazas MA; Gimeno E; Muñoz-Tudurí M
Gastroenterol Hepatol; 2012 Jan; 35(1):1-7. PubMed ID: 22178503
[TBL] [Abstract][Full Text] [Related]
40. Prospective cohort study of gastrointestinal complications and vascular diseases in patients taking aspirin: rationale and design of the MAGIC Study.
Origasa H; Goto S; Shimada K; Uchiyama S; Okada Y; Sugano K; Hiraishi H; Uemura N; Ikeda Y;
Cardiovasc Drugs Ther; 2011 Dec; 25(6):551-60. PubMed ID: 21842134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]